Visa Acquires BioCatch for $2.4 Billion
Visa agreed on August 3 to acquire behavioral-biometrics and fraud-detection firm BioCatch for $2.4 billion in cash from Permira-advised funds and other shareholders, CNBC reported. BioCatch analyzes interaction signals such as keystroke timing, touch gestures, and device handling to identify fraud before payment. The transaction requires regulatory approvals and is targeted to close by the end of Visa's fiscal second quarter of 2027.
Visa agreed to acquire BioCatch for $2.4 billion in cash, expanding the card network's fraud-prevention portfolio with behavioral-biometrics technology used by banks. CNBC reported that Visa is buying the Tel Aviv-based company from private equity firm Permira and other investors; the deal remains subject to regulatory approvals and is expected to close by the end of Visa's fiscal second quarter in 2027.
BioCatch's platform analyzes behavioral and device-level signals, including keystroke timing, touch-screen gestures, pressure, and device handling, to distinguish legitimate users from suspected fraudsters or automated attacks. Payments Dive, citing the transaction announcement, reported that the system uses AI and machine learning to evaluate thousands of application, behavioral, device, and network signals in real time.
The acquisition is an all-cash deal. Law360 reported that Permira became BioCatch's majority stakeholder more than two years ago at a $1.3 billion valuation, placing the announced purchase price materially above that earlier valuation.
A fraud tool deployed before payment
The transaction adds a security layer that operates upstream of card authorization. Rather than relying only on transaction attributes or static authentication factors, behavioral biometrics evaluates how a user interacts with a banking application, login portal, or transfer flow.
According to American Banker, BioCatch monitors more than 3,000 signals and is used to detect account takeovers, scams, mule-account activity, and fraudulent account applications. The publication noted that BioCatch's stated footprint includes three of the four largest U.S. banks by assets, including Wells Fargo. It also cautioned that the company's reported user, client, and session figures have not been independently verified.
Company figures cited by CNBC, Payments Dive, and The Jerusalem Post put BioCatch's footprint at more than 350 banking clients across 21 countries, 760 million users, and 1.8 billion protected devices. CNBC reported that Visa's network connects nearly 14,500 financial institutions and processes more than 329 billion transactions annually, with payment volume above $17 trillion.
Andrew Torre, Visa's president of value-added services, said in the announcement: "BioCatch will help our clients stop fraud before it reaches the point of payment." Torre also put the global annual cost of account takeovers and scams at about $1 trillion, according to Payments Dive and The Jerusalem Post.
AI-era fraud and vendor concentration
The deal arrives as payments companies and banks face more convincing social-engineering attacks, account takeovers, and automated fraud attempts enabled by generative AI. CNBC described the acquisition as part of Visa's expansion of its value-added services business, which sells fraud prevention, cybersecurity, and analytics products to financial institutions.
For fraud teams, behavioral signals can complement device intelligence, transaction monitoring, and identity verification because they provide a continuous risk signal during a user session. Industry deployments of comparable systems commonly require careful model calibration: accessibility tools, changed devices, unusual travel, and legitimate changes in user behavior can otherwise create false positives. The relevant operational question is not whether behavioral data replaces existing controls, but how it is combined with case-management workflows, step-up authentication, and human review.
American Banker identified a commercial consideration for bank customers already using BioCatch: after closing, some banks would obtain a fraud-detection service from a company with which they also negotiate card-network terms. Eric Grover of Intrepid Ventures told the publication that bundled services can simplify vendor management, "albeit at the cost of reducing banks' negotiating leverage."
BioCatch was founded in 2011 by Avi Turgeman and the late Benny Rosenbaum, according to The Jerusalem Post. The publication reported that the company employs about 280 people, approximately half in Israel.
Key Points
- 1Visa's $2.4 billion purchase brings behavioral biometrics into its fraud portfolio, extending risk detection from payment authorization into earlier user-session activity.
- 2BioCatch evaluates thousands of behavioral, device, and network signals, giving banks a complementary control against account takeovers, scams, and automated fraud.
- 3Comparable fraud-platform consolidation can simplify procurement, while industry experience shows it may also reduce large banks' vendor negotiating leverage.
Scoring Rationale
This is a large security acquisition involving a global payments network and a behavioral-biometrics platform used by hundreds of banks. It matters to ML and fraud practitioners because it elevates session-level behavioral intelligence as a component of defenses against AI-enabled account takeover and scam activity.
Sources
Public references used for this report.
Practice with real Payments data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Payments problems
